MOLN
USDMolecular Partners AG American Depositary Shares
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$4.110
High
$4.265
Low
$3.720
Volume
0.01M
Company Fundamentals
Market Cap
146.2M
Industry
Biotechnology
Country
Switzerland
Trading Stats
Avg Volume
0.00M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025
Poster presentation outlines potential of CD3 Switch-DARPin T cell engager (TCE) using an AND-gate to overcome limitations of other TCEs Demonstrated selective T cell cytotoxicity against cells co-expressing
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a clinical-stage biotech company
Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025
IND application filed for MP0712, the Company's lead Radio-DARPin candidate targeting DLL3 and co-developed with Orano Med, with Phase 1 initiation expected before year end 2025 First patient images from MP0712
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.